BRICS is building something bigger than an economic alliance

When BRICS is mentioned in Western media, the discussion almost always revolves around geopolitics, trade, or rivalry with the United States and the European Union. The organization is often portrayed as a project whose primary purpose is to challenge the existing world order.

However, the more I read about what is actually taking place within the grouping, the clearer it becomes that some of the most interesting developments are happening far from the headlines.

One such area is healthcare and medical innovation. Over the past few years, BRICS member states have been building increasingly close cooperation in research, pharmaceutical production, and advanced medical technologies. This is not merely about exchanging expertise; it is about creating independent structures for the development, manufacturing, and distribution of products that have often been controlled by a limited number of players.

To me, this is yet another sign of how the world is gradually changing.

A lesson from the pandemic

The pandemic served as a wake-up call for much of the world. Governments suddenly realized how vulnerable they were when supply chains broke down, factories closed, and access to essential products became uncertain.

Developing countries were hit particularly hard, often finding themselves at the back of the line when vaccines and medical equipment were being distributed.

Against this backdrop, BRICS initiatives become easier to understand. The ambition is not simply to increase pharmaceutical production. Equally important is reducing dependence on a small number of dominant companies and creating better conditions for people in Africa, Asia, and Latin America to gain access to modern healthcare.

When strengths complement one another

What is fascinating is how different member countries contribute their own areas of expertise.

India has long been a global leader in affordable pharmaceuticals. China has made major advances in digital health, artificial intelligence, and medical software. Russia possesses extensive experience in nuclear medicine and advanced diagnostics, while Brazil has developed strong capabilities in public healthcare and medical research.

At the same time, Iran, Egypt, the United Arab Emirates, Indonesia, and Ethiopia contribute investment, industrial capacity, and rapidly growing markets.

When viewed as a whole, a picture emerges that is rarely discussed in the West. Step by step, the partnership is evolving into a network where knowledge, technology, and resources can be shared in ways that were once difficult to imagine.

The treatments of the future

One particularly exciting area of development involves advanced biological medicines and modern cancer therapies.

For a long time, these treatments have been so expensive that they have effectively been accessible only to wealthy countries or affluent patients. Efforts are now underway to develop more affordable alternatives that could make the same types of treatment available to significantly larger populations.

If these initiatives succeed, the consequences could be far greater than many people realize. Ultimately, this is about people's ability to receive healthcare when they need it, regardless of where in the world they live.

More than healthcare

The cooperation also has a clear strategic dimension. In Europe, discussions often focus on energy, defense, and security. For many countries, access to medicines and medical technology is just as important.

A society that cannot secure its most basic needs becomes vulnerable. Trade disputes, sanctions, or international crises can quickly affect everything from pharmaceutical supplies to advanced medical treatment.

For that reason, these initiatives are as much about resilience and self-reliance as they are about research and innovation.

A quiet transformation

Of course, many challenges remain. Regulatory systems differ between member states, patent issues create obstacles, and infrastructure development remains uneven. Despite this, the overall direction appears clear.

While much of the world's attention is focused on conflicts and geopolitical tensions, extensive efforts are simultaneously underway to build new scientific and industrial partnerships. I believe this is one of the most underestimated developments within BRICS today.

When future historians look back on our era, they may not primarily remember summit meetings and diplomatic declarations. Instead, they may talk about how large parts of the world began building their own systems for research, production, and technological development.

If that proves to be the case, healthcare cooperation within BRICS may turn out to be one of the most important transformations of the 2020s. Not because it changes the balance of power in the world, but because it could give millions of people a better chance to live longer, healthier, and more secure lives.

The author is a NewsVoice freelancer specializing in geopolitics, with a focus on BRICS, Russia, and Belarus.

The views don't necessarily reflect those of China Daily.

If you have a specific expertise, or would like to share your thought about our stories, then send us your writings at opinion@chinadaily.com.cn, and comment@chinadaily.com.cn.